Literature DB >> 12660818

p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice.

Béatrice Eymin1, Camille Leduc, Jean-Luc Coll, Elisabeth Brambilla, Sylvie Gazzeri.   

Abstract

Until recently, the ability of ARF (human p14(ARF), murine p19(ARF)) tumour-suppressor protein, encoded by the INK4A/ARF locus, to inhibit cell growth in response to various stimuli was related to its ability to stabilize p53 through the so-called ARF/MDM2/p53 pathway. However, recent data have demonstrated that ARF is not implicated in this unique p53-dependent pathway. By use of transient and stable expression, we show here that human p14(ARF) inhibits the growth of human tumoral cells lacking functional p53 by inducing a transient G(2) arrest and subsequently apoptosis. This p14(ARF)-induced G(2) arrest was correlated with inhibition of CDC2 activity, inactivation of CDC25C phosphatase and induction of the CDK inhibitor p21(WAFI). Apoptosis was demonstrated using Hoechst 33352 staining, proteolytic activation of caspase-3 and PARP cleavage. Similar results were obtained in experiments with cells synchronized by hydroxyurea block. Importantly, we were able to reproduce these effects 'in vivo' by showing that p14(ARF) inhibits the growth of p53 nullizygous human tumours in nude mice and induces the regression of p53 -/- established tumours. In these experiments, tumoral regression was associated with inhibition of cell proliferation as well as induction of apoptosis confirming the data obtained in cell lines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12660818     DOI: 10.1038/sj.onc.1206303

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  35 in total

1.  p14ARF activates a Tip60-dependent and p53-independent ATM/ATR/CHK pathway in response to genotoxic stress.

Authors:  Béatrice Eymin; Paule Claverie; Caroline Salon; Camille Leduc; Edwige Col; Elisabeth Brambilla; Saadi Khochbin; Sylvie Gazzeri
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

2.  EAPP, a novel E2F binding protein that modulates E2F-dependent transcription.

Authors:  Michael Novy; Regina Pohn; Peter Andorfer; Tina Novy-Weiland; Barbara Galos; Ludwig Schwarzmayr; Hans Rotheneder
Journal:  Mol Biol Cell       Date:  2005-02-16       Impact factor: 4.138

3.  P14ARF inhibits human glioblastoma-induced angiogenesis by upregulating the expression of TIMP3.

Authors:  Abdessamad Zerrouqi; Beata Pyrzynska; Maria Febbraio; Daniel J Brat; Erwin G Van Meir
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

4.  VEGF165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a β1 integrin/VEGFR autocrine loop.

Authors:  Asma Boudria; Cherine Abou Faycal; Tao Jia; Stephanie Gout; Michelle Keramidas; Chloé Didier; Nicolas Lemaître; Sandra Manet; Jean-Luc Coll; Anne-Claire Toffart; Denis Moro-Sibilot; Corinne Albiges-Rizo; Véronique Josserand; Eva Faurobert; Christian Brambilla; Elisabeth Brambilla; Sylvie Gazzeri; Beatrice Eymin
Journal:  Oncogene       Date:  2018-09-07       Impact factor: 9.867

5.  CDKN2A, CDK1, and CCNE1 overexpression in sebaceous gland carcinoma of eyelid.

Authors:  Tatsuya Yunoki; Tetsushi Hirano; Yoshiaki Tabuchi; Yukihiro Furusawa; Misako Torigoe; Takahiko Nakajima; Johji Imura; Atsushi Hayashi
Journal:  Int Ophthalmol       Date:  2019-09-30       Impact factor: 2.031

6.  A 12-gene genomic instability signature predicts clinical outcomes in multiple cancer types.

Authors:  Rama K R Mettu; Ying-Wooi Wan; Jens K Habermann; Thomas Ried; Nancy Lan Guo
Journal:  Int J Biol Markers       Date:  2010 Oct-Dec       Impact factor: 2.659

7.  Nuclear trafficking of EGFR by Vps34 represses Arf expression to promote lung tumor cell survival.

Authors:  D Dayde; M Guerard; P Perron; A-S Hatat; C Barrial; B Eymin; S Gazzeri
Journal:  Oncogene       Date:  2015-12-21       Impact factor: 9.867

Review 8.  Roles of ARF tumour suppressor protein in lung cancer: time to hit the nail on the head!

Authors:  Ruju Vashi; Bhoomika M Patel
Journal:  Mol Cell Biochem       Date:  2021-01-03       Impact factor: 3.396

9.  Loss of p19(Arf) facilitates the angiogenic switch and tumor initiation in a multi-stage cancer model via p53-dependent and independent mechanisms.

Authors:  Danielle B Ulanet; Douglas Hanahan
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

10.  Mitochondrial p32 is a critical mediator of ARF-induced apoptosis.

Authors:  Koji Itahana; Yanping Zhang
Journal:  Cancer Cell       Date:  2008-06       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.